Frailty may help to predict intensive care unit (ICU) patient outcome. The Dalhousie Clinical Frailty Scale (DCFS) is validated to assess frailty in ambulatory settings but has not been investigated in Australian ICUs. We conducted a prospective threemonth study of patients admitted to a tertiary level ICU. Within 24 hours of ICU admission, the next of kin or nurse in charge assigned a DCFS score to the patient. Data were obtained to assess the association between frailty and patient outcome. The DCFS score was completed in 205 of 348 (59%) of eligible patient admissions. The mean DCFS score was 3.2 (±1.6). Overall frailty (DCFS >4) occurred in 28 of 205 patients (13%, confidence interval 9% to 17%), 13 of 93 (15%, confidence interval 10% to 25%) in patients aged >65 years and 5 of 11 (45%, confidence interval 21% to 71%) in those >85 years. Patients with chronic liver disease (P <0.001) and end-stage renal failure (P=0.009) were more likely to be frail. The DCFS score was not significantly associated with ICU or hospital mortality: odds ratio 0.98 (95% confidence interval 0.6 to 1.6) and odds ratio 1.07 (95% confidence interval 0.8 to 1.4), respectively. However, after adjustment for illness severity and requirement for palliative care, the DCFS score was significantly associated with increased (log) hospital length-of-stay (P=0.04) and age (P=0.001). Approximately 1 in 10 ICU patients were frail and this frequency increased with age. The DCFS was associated with patient age and comorbidities and potentially predicts increased hospital length-of-stay but not other outcomes. Strategies to improve compliance with DCFS completion are needed.
Frailty is a biological syndrome of reduced resistance and reserve to stressors resulting from physiological decline, which predisposes to adverse outcomes [1] [2] [3] . The concept of frailty incorporates the complex interaction between patients' comorbidities, functional state, physiological reserve and age and is marked by the accumulation of numerous health deficits 4, 5 . There exists shared features between frailty and critical illness, specifically sarcopenia, cachexia and systemic inflammation. Accordingly, there is increased interest in their shared associations with poor functional outcome 6, 7 .
Frailty has been shown to be predictive of long-term risk-of-death, hospital admission and institutionalisation in geriatric populations 1,8,9 . In addition, frailty is increasingly recognised as an improved measure of pre-hospital function, and thus is increasingly utilised as a predictor of adverse postoperative outcomes 10, 11 .
Recent critical care publications have suggested that the consideration of frailty has the potential to improve prognostication in critically ill patients 12, 13 . The current prevalence of frailty in critical care patients is unknown and it is also unknown whether the assessment of frailty impacts upon patient outcomes. Despite this, the routine quantification of frailty in intensive care unit (ICU) patients appears to be a desirable adjunct to existing tools.
Unfortunately, many of the validated frailty tools are complex and lack feasibility in wider usage 1, 2, 14 . This creates a major barrier to the routine quantification of frailty in ICU patients. Recently, however, the simplified Dalhousie Clinical Frailty Scale (DCFS) was derived and validated from the complex 70-point frailty index, to increase its ease of application by clinicians 1 . To our knowledge, no current tool has been validated in ICU patients and no study has assessed the utility of the DCFS in ICU patients in Australia.
Accordingly, we aimed to prospectively assess feasibility using the number (%) of completed DCFS scores, while the potential prognostic utility of the DCFS scores was determined by exploring the relationship between the DCFS, patient comorbidities, patient outcomes and lengthof-stay (LOS).
Methods

Study design and ethical considerations
We performed a prospective pilot feasibility study of the use of the DCFS in a 22-bed tertiary referral, mixed medicalsurgical ICU at the Austin Hospital in Melbourne, Victoria. The hospital receives approximately 2200 admissions per year and is the state referral service for liver transplantation, complex thoracic aortic surgery and acute spinal cord injuries. The local Human Research Ethics Committee approved the study and waived the need for written informed consent (Approval No.: H2013/05097).
Patient inclusion criteria
All patients admitted to ICU between 1 October 2012 and 31 December 2012 were screened for eligibility upon arrival in the ICU. Exclusion criteria included anticipated death within 24 hours, admission for palliative care or admission for the purposes of organ donation. We also excluded overnight admissions in the adjacent high dependency post-anaesthetic recovery unit of our ICU.
The Dalhousie Clinical Frailty Scale
The DCFS is a visual and written analog scale of 1 to 9, with 1 representing normal function and 9 representing terminal illness (Figure 1) 1 . Frailty is defined as a patient having a score >4 1 . This equates to a patient having limited dependence on others for activities of daily living. To further explore the impact of increasing frailty, frail patients were further subdivided into mildly frail (DCFS scores 5 to 6) and severely frail (DCFS scores ≥7). Written permission was sought and obtained for the use of the DCFS.
Method of patient screening and assessment
Each patient was assessed on his or her first ICU admission only. The bedside nurse approached the patient's next of kin (NOK) at the bedside and introduced the DCFS audit tool. The DCFS was introduced using a standardised verbal script. The NOK was asked to assign a score on a DCFS audit form that best described the patient's level of function prior to ICU admission. All nursing staff underwent a series of lectures introducing the research project, explaining their role and familiarising them with the standardised introduction and DCFS score. If NOK was not available in the first 24 hours, the nurse in charge (NIC) documented the most appropriate score after review of the patient's medical record. The NIC was chosen on the basis that they are among the most senior and experienced nurses and have the benefit of these qualities in conducting a frailty assessment. The 24-hour period was chosen on a pragmatic real-world basis in an attempt to reflect potential usage of the DCFS upon patient admission to ICU. Although aware of the study, treating medical staff were blinded to the frailty score assigned to the patient.
Data collection
We collected data from the intensive care database (AORTIC © , ANZICS CORE, Carlton, Victoria; SMR Software, Grand Rapids, MN, USA; MedTrak Data Systems Inc., Richmond, TX, USA) including patient comorbidities. Data was collected on calculated chronic health scores, risk-of-death scores and other admission diagnoses. Patient severity of illness was determined using the Acute Physiology and Chronic Health Evaluation III risk-of-death score 15 .
Outcome measures
Outcomes measured included both hospital and ICU mortality, hospital and ICU LOS and discharge destination. Subgroup analysis was performed for patients whose ICU LOS was greater than 24 hours and for those aged older than 65 years. Feasibility of the use of the DCFS was determined by the number (%) of completed DCFS forms.
Statistical analysis
All analysis was performed using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA). Variables were examined for normality and log-transformed where appropriate. Group comparisons were made using chi-square tests for equal proportions with results presented as numbers (percentages). Normally distributed variables were compared using student t-tests and presented as means with standard deviation whilst non-parametric data were compared using Wilcoxon rank-sum tests and presented as medians with interquartile ranges.
Univariate relationships between frailty score and log of LOSs were determined using linear regression and are reported as parameter estimates (± standard error [SE]) while univariate relationships with binomial outcomes were determined using logistic regression and reported as odds ratios (ORs) with 95% confidence intervals (CIs). Additional multivariable sensitivity analysis was performed on all outcomes adjusting for illness severity and the institution of palliative therapies. A two-sided P-value of 0.05 was considered to be statistically significant.
Results
Patient demographics
During the three-month period, there were 505 admissions and 348 were eligible for inclusion in the study ( Figure 2 ). We obtained a DCFS score in 205 of 348 (59%) patients. Overall, 121 of 205 (59%) patients were male. The mean age was 60 (±17.4) years. Ninety-four of 205 (46%) patients were postoperative patients. The mean Acute Physiology and Chronic Health Evaluation III score was 54 (±26), with a median predicted risk-of-death of 5% (1% to 18%).
Comparison of DCFS scored and non-scored patients.
There were significant differences between scored and non-scored patients in our study. The 143 patients who were not scored were more likely to be postoperative (62.2% versus 45.9%, P=0.003), have shorter ICU LOSs (1. (P=0.912), baseline Acute Physiology and Chronic Health Evaluation III score (P=0.08) or any of the pre-existing comorbidities (P >0.14).
Dalhousie Clinical Frailty Scale scores
The distribution of DCFS in enrolled patients is shown in Figure 3 . DCFS scores were assigned by the NOK in 150 of 205 (27%) cases and by the NIC in 55 of 205 (73%) cases ( Table 1 ). The overall mean DCFS score was 3.2 (±1.6). Mean scores assigned by the NIC and NOK were 3.3 (±1.7) and 3.1 (±1.5), respectively (P=0.39). For those scored as not frail, frail and severely frail, the mean DCFS scores were 2.7 (±1.1), 5.4 (±0.5) and 7.2 (±0.6), respectively.
Frequency of frailty
Overall, 28 of 205 patients (13%, CI 9% to 17%) were frail (DCFS >4) ( Table 2 ). Frailty occurred in 13 of 93 (15%, CI 10% to 25%) patients aged greater than 65 years and in 5 of 11 (45%, CI 21% to 71%) patients aged greater than 85 years. Twenty of 157 (13%, CI 9% to 19%) patients who were admitted to ICU for greater than 24 hours were frail.
Elderly patient characteristics
Patients aged greater than 65 years composed 93 (45%) of 205 scored patients. Compared with patients aged less than 65 years, they had statistically significant higher mean DCFS scores (3.4 [± 1.4] versus 2.9 [±1.7], P=0.028) and were less likely to have chronic liver disease (2 of 93 [2%] versus 17 of 112 [15%] P=0.001). There was no statistically significant difference between the older and younger age groups in the patients with DCFS scores >4 (P=0.35) or in the presence of chronic renal failure (P=0.38), respiratory disease (P=1), cardiovascular disease (P=0.5), gender distribution (P= 0.59) or admission status (P= 0.34).
Patients admitted for more than 24 hours
Patients admitted to the ICU for longer than 24 hours comprised 157 (77%) of 205 scored patients. Compared to patients admitted for less than 24 hours, patients admitted for greater than 24 hours were less likely to have chronic renal failure (1 of 157 [0.63%] versus 4 of 48 [8%], P=0.01), and more likely to be discharged to a rehabilitation facility (29 of 157 [18%] versus 3 of 48 [6%], P=0.04). There was a trend for patients admitted for greater than 24 hours to have lower mean DCFS scores (3.1 [±1.5]) compared with those admitted for less than 24 hours (3.5 [±1.6]), P=0.06. Otherwise, there were no statistically significant differences in DCFS >4 scores (P=0.49), chronic liver disease (P= 0.41), respiratory disease (P=0.05), cardiovascular disease (P=1.00), gender distribution (P=0.39) or admission status (P=0.74) based on admission for less than versus greater than 24 hours. 
Association between frailty score and patient comorbidities
The DCFS was associated with age, chronic liver disease and end-stage kidney disease. Every one-year increase in age resulted in the DCFS score increasing by 0.02 (±0.006, P=0.001). Patients with chronic liver disease had a DCFS score 1.47 (± 0.36, P <0.001) points higher than that of those without liver disease and patients with end-stage kidney disease had a score 1.86 (± 0.70, P=0.009) higher than those without end-stage kidney disease.
Association between frailty score and patient outcomes
Mortality in ICU was 7 out of 205 (3%), whilst in-hospital mortality was 26 out of 205 (13%). Mortality for all frail patients (DCFS >4) was 4 of 28 (14%). Overall, median (interquartile range) LOS in the ICU was 2.3 (1 to 4.5) days and total hospital admission LOS was 12.6 (7 to 26) days. Regarding discharge location, 126 of 205 (61%) were discharged home and 32 of 205 (16%) were discharged to rehabilitation facilities.
The relationship between the DCFS score and outcome is presented in Table 3 . Overall, the DCFS score was not associated with ICU mortality (OR 0.98, 95% confidence interval 0.6 to 1.6), in-hospital mortality (OR 1.07, 95% confidence interval 0.8 to 1.4) or discharge to rehabilitation facilities (OR 1.00, 95% confidence interval 0.8 to 1.3). When adjusted for illness severity and requirement for palliative care, there was a weak but positive association between the DCFS score and an increases hospital LOS (0.1 ± 0.05, P=0.04). Across all patients, there persisted a negative relationship between the DCFS score and ICU LOS; this was only significant in patients aged greater than 65 years (-0.17 ± 0.08, P=0.04).
Discussion
Summary of major findings
We conducted a three-month prospective observational study to assess the frequency of pre-admission frailty and its associations with patient outcomes in our ICU. The compliance with completing the DCFS was just over half of all eligible admissions. Approximately one in ten patients were frail (DCFS score >4) and this proportion increased with patient age.
DCFS scores increased with increasing hospital LOS, patient age and presence of chronic liver and renal disease. DCFS scores, however, were not associated with ICU or hospital mortality for the entire cohort overall, nor in any of the pre-specified sub-groups.
In patients aged older than 65 years and patients admitted for longer than 24 hours, the DCFS score was associated with comorbidities. There was a negative relationship between frailty score and the ICU LOS across the entire cohort and this was only significant in patients aged over 65 years.
Comparison with previous studies
Our study is the first to use the DCFS to assess frailty and its association with outcomes in an Australian ICU. To date, research has focused on exploring surrogate markers such as age, number of comorbidities and biological parameters to prognosticate on ICU outcome [15] [16] [17] [18] [19] . However, these parameters are imperfect predictors of short-or long-term ICU outcome 20, 21 . The assessment of frailty may provide useful additional information to assist in this prognostication. The proportion of patients classified as frail varies between 5% and 50% depending on the diagnostic tool and population being studied 1, 3, 10, 22, 23 . Whilst our finding of 13% in critically ill patients grossly reflects the prevalence in major community studies, it is lower than other studies in critical care 24, 25 . This may reflect the wider inclusion criteria used in our study.
The DCFS has been used in a limited number of other ICU studies to date. Bagshaw et al prospectively assessed 421 Canadian patients older than 50 years admitted to intensive care for longer than 24 hours 24 . In this more select group of patients, the median frailty score was 4 and 32% had a DCFS score >4. Patients with DCFS scores >4 were more likely to die in hospital and have a lower quality of life at 12-month follow-up. Our lower proportion of observed frailty may reflect a broader inclusion of age and ICU LOS. Unlike the study of Bagshaw et al, we did not observe increased overall mortality with increasing DCFS scores.
A similar prospective study by Le Maguet et al examined the DCFS and the frailty phenotype in French ICUs 25 . In 196 patients, the prevalence of frailty, as defined by DCFS scores >4, was 23%. Frail patients had a hazard ratio of 2.4 for sixmonth mortality. However, the high number of patients with traumatic brain injury (20%) or admitted post cardiac arrest (8%) potentially confounds these findings.
Other small retrospective studies utilising the DCFS in the ICU have produced conflicting results. Charles et al looked at clinician-assigned DCFS scores in 112 ICU patients over 80 years of age. Similar to our results, they found a median DCFS score of 4, with no relationship between DCFS and patient outcomes 26 . Masud et al used the DCFS in 42 elderly patients with severe burns and found that DCFS was only associated with 12-month mortality 27 .
Preoperative frailty, as assessed by a variety of tools, is associated with adverse postoperative outcomes 10, 11, [28] [29] [30] [31] [32] . Specifically, the DCFS, in conjunction with other biochemical and function measures, was predictive of 30-day and oneyear mortality in cardiac surgery patients. The DCFS had a better long-term prognostic ability compared to existing tools in this setting 33 . The fact that most cardiac surgical patients are elective differs from the unscheduled nature of many ICU admissions.
The ideal use in whom, and by whom, of the DCFS in critical care remains unclear. Our compliance, with predominately NIC scoring, was just over half and this is consistent with the two major ICU studies, with each scoring less than 60%. Potential reasons in our study are high patient turnover and the added workload to bedside nursing staff. The comparison between scored and nonscored patients suggest that the non-scored population were more likely to be postoperative and have lower illness severity scores and therefore lower ICU and hospital LOSs and mortality. The DCFS was designed and validated to be a clinician-based judgement tool and critical care practitioners could be a valid source of scoring. This is suggested by our finding of no statistical difference between NOK scores and Associate Nurse Unit Manager scores. However, the validation of the DCFS requires further investigation.
Implications for clinicians and policy makers
Although frailty may intuitively be appealing as a riskstratification tool, we have shown it may be difficult to apply to ICU patients in a manner that is reproducible and logistically feasible in an environment with rapid patient turnover. Its potential to provide additional prognostic information over and above that provided by illness severity scores, age and comorbidities remains unclear.
Our study suggests that applying the DCFS may not be feasible for all ICU patients. It is possible that it may be more useful in specific populations who are likely to remain in ICU for longer periods.
Study strengths and limitations
Our study is the first to examine the utility of a validated frailty score in an Australian ICU population. We asked the patients' NOK to assign scores to decrease the risk of clinician bias. We were able to document the proportion of ICU admissions who were frail and the associations with this status.
Our study has several limitations, chiefly its single-centre design, small sample size and 50% non-compliance rate with DCFS scoring. A further limitation was that we did not explore longer-term outcomes and rates of hospital re-admission. The high number of chronic liver disease patients admitted to our ICU may influence the associations between frailty, chronic liver disease and patient outcome. On the other hand, exclusion of a small number of patients who were likely to die shortly after admission (seven patients) would have underestimated the DCFS. We further acknowledge that interviewer and recorder bias may have influenced our results and, without a measure of inter-rater reliability, the validity of our findings can't be confirmed.
Conclusions
During this three-month prospective study we found that one in ten patients in our ICU were frail. The DCFS was positively associated with age, chronic liver disease and chronic renal disease and, after adjustment for variables, there existed a weak association with increased hospital LOS. However, DCFS scores were not associated with ICU or hospital mortality. We also found that that NOK-determined DCFS scoring in all patient groups was of limited feasibility in the ICU, although scoring may be more feasible in those patients admitted for longer than 24 hours. Further research is required to overcome the logistical obstacles posed by frailty assessment in ICU.
